Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes

被引:17
|
作者
Chen, M.
Howe, D.
Leduc, B.
Kerr, S.
Williams, D. A.
机构
[1] CombinatoRx Inc, Dept Preclin Dev & Formulat, Cambridge, MA 02142 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA USA
[3] Vertex Pharmaceut Inc, Drug Innovat Pharmacokinet Dept, Cambridge, MA USA
关键词
chloramphenicol; human liver microsomes; glucuronidation; enzyme kinetics; chloramphenicol O-glucuronides; liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS); DRUG-METABOLISM; TOXICITY; DISPOSITION; MODEL;
D O I
10.1080/00498250701620734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study reports the development of a specific and sensitive liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS) assay for the quantification of the in vitro O-glucuronidation of chloramphenicol (Cl?), the determination of the kinetic parameters for the O-glucuronidation of CP in pooled human liver microsomes (HLM), the biosynthesis of the CP glucuronides (CPGlu), and identification of the structures of CPGlu by H-1-nuclear magnetic resonance (NMR) and MS. Two glucuronyl derived metabolites of CP were obtained from the incubation of alamethicin-activated HLM with CP and uridine 5'-diphosphoglucuronic acid (UDPGA) in pH 7.4 TRIS buffer. Their identification and structural confirmation were achieved by beta-glucuronidase hydrolysis, in the presence and absence of UDPGA, and by H-1-NMR and LC-MS/ MS. These two metabolites were biosynthesized, isolated, and purified using high-performance liquid chromatography (HPLC). Their structures were further identified as the 1-O-CPGlu (the minor glucuronide formed at the secondary alcohol of CP) and 3-O-CPGlu (the major glucuronide formed at the primary alcohol of CP) by LC-MS/MS and two-dimensional NMR. The enzymatic kinetic parameters K-m and V-max in HLM for the 3-O-CPGlu were determined to be 650 mu M and 0.26 nmoles min(-1) mg(-1), respectively, and for the 1-O-CPGlu to be 301 mu M and 0.014 nmoles min(-1) mg(-1), respectively. This study also provides a sensitive and specific method for the measurement of in vitro CP-UDP-glucuronosyltransferase (UGT) activity.
引用
收藏
页码:954 / 971
页数:18
相关论文
共 50 条
  • [41] In vitro selection and characterization of DNA aptamers recognizing chloramphenicol
    Mehta, Jaytry
    Van Dorst, Bieke
    Rouah-Martin, Elsa
    Herrebout, Wouter
    Scippo, Marie-Louise
    Blust, Ronny
    Robbens, Johan
    JOURNAL OF BIOTECHNOLOGY, 2011, 155 (04) : 361 - 369
  • [42] Glucuronidation of thyroxine in human liver, jejunum, and kidney Microsomes
    Yamanaka, Hiroyuki
    Nakajima, Miki
    Katoh, Miki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) : 1642 - 1648
  • [43] GLUCURONIDATION OF ZIDOVUDINE (AZIDOTHYMIDINE) BY HUMAN LIVER-MICROSOMES
    SIM, SM
    BACK, DJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : P321 - P322
  • [44] Identification of the UDP-Glucuronosyltransferase Isozyme Involved in Senecionine Glucuronidation in Human Liver Microsomes
    He, Yu-Qi
    Liu, Yong
    Zhang, Bin-Feng
    Liu, Hui-Xin
    Lu, Yan-Liu
    Yang, Li
    Xiong, Ai-zhen
    Xu, Ling-Ling
    Wang, Chang-Hong
    Yang, Ling
    Wang, Zheng-Tao
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (04) : 626 - 634
  • [45] In vitro glucuronidation of methyl gallate and pentagalloyl glucopyranose by liver microsomes
    Jiamboonsri, Pimsumon
    Pithayanukul, Pimolpan
    Bavovada, Rapepol
    Leanpolchareanchai, Jiraporn
    Gao, Song
    Hu, Ming
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (04) : 292 - 303
  • [46] Isoflavones modulate the glucuronidation of estradiol in human liver microsomes
    Pfeiffer, E
    Treiling, CR
    Hoehle, SI
    Metzler, M
    CARCINOGENESIS, 2005, 26 (12) : 2172 - 2178
  • [47] Characterization of in vitro bioactivation of Noscapine in Human Liver Microsomes
    Fang, Zhong-Ze
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2010, 42 : 79 - 79
  • [48] Reduction and glucuronidation of naftazone by human and rat liver microsomes
    Herber, R
    Hercelin, B
    VanCantfort, J
    DeGraeve, J
    FournelGigleux, S
    Taguchi, T
    Magdalou, J
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (12) : 1305 - 1314
  • [49] Characterization of in vitro metabolites of cudratricusxanthone A in human liver microsomes
    Sim, Juhee
    Choi, Eunhwa
    Jeong, Gil-Saeng
    Lee, Sangkyu
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (05) : 325 - 336
  • [50] METABOLISM OF KETOTIFEN BY HUMAN-LIVER MICROSOMES - INVITRO CHARACTERIZATION OF A TERTIARY AMINE GLUCURONIDATION
    LEBIGOT, JF
    CRESTEIL, T
    KIECHEL, JR
    BEAUNE, P
    DRUG METABOLISM AND DISPOSITION, 1983, 11 (06) : 585 - 589